BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol 2020;65:176-88. [PMID: 31874281 DOI: 10.1016/j.semcancer.2019.12.007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 74] [Article Influence: 20.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Li C, Liao S, Tu Y, Sun S, Yao F, Li Z, Wang Z. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer. Cancer Biol Ther 2022;23:1-11. [PMID: 36137220 DOI: 10.1080/15384047.2022.2125260] [Reference Citation Analysis]
2 Shasha T, Gruijs M, van Egmond M. Mechanisms of colorectal liver metastasis development. Cell Mol Life Sci 2022;79:607. [DOI: 10.1007/s00018-022-04630-6] [Reference Citation Analysis]
3 Bertolini G, Roato I. The road of NSCLC stem cells toward bone metastases. Bone Rep 2022;17:101619. [PMID: 36110341 DOI: 10.1016/j.bonr.2022.101619] [Reference Citation Analysis]
4 Wang J, Liu T, Huang T, Shang M, Wang X. The mechanisms on evasion of anti-tumor immune responses in gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.943806] [Reference Citation Analysis]
5 Li D, Zhang X, Jiang L. Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1000807] [Reference Citation Analysis]
6 Wang J, Xie Y, Qin D, Zhong S, Hu X. CXCL12, a potential modulator of tumor immune microenvironment (TIME) of bladder cancer: From a comprehensive analysis of TCGA database. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1031706] [Reference Citation Analysis]
7 Rajtmajerová M, Trailin A, Liška V, Hemminki K, Ambrozkiewicz F. Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment. Cancers 2022;14:5450. [DOI: 10.3390/cancers14215450] [Reference Citation Analysis]
8 Wu X, Qian L, Zhao H, Lei W, Liu Y, Xu X, Li J, Yang Z, Wang D, Zhang Y, Zhang Y, Tang R, Yang Y, Tian Y. CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101809] [Reference Citation Analysis]
9 Sun H, Wang X, Wang X, Xu M, Sheng W. The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death Dis 2022;13:874. [PMID: 36244987 DOI: 10.1038/s41419-022-05320-8] [Reference Citation Analysis]
10 Wang Z, Zhong H, Liang X, Ni S. Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. Front Immunol 2022;13:1024921. [DOI: 10.3389/fimmu.2022.1024921] [Reference Citation Analysis]
11 Liu GH, Chen T, Zhang X, Ma XL, Shi HS. Small molecule inhibitors targeting the cancers. MedComm (2020) 2022;3:e181. [PMID: 36254250 DOI: 10.1002/mco2.181] [Reference Citation Analysis]
12 Luciano M, Krenn PW, Horejs-hoeck J. The cytokine network in acute myeloid leukemia. Front Immunol 2022;13:1000996. [DOI: 10.3389/fimmu.2022.1000996] [Reference Citation Analysis]
13 Tian R, Sun Y, Han X, Wang J, Gu H, Wang W, Liang L. Identification and validation of prognostic autophagy-related genes associated with immune microenvironment in human gastric cancer. Aging (Albany NY) 2022;14:7617-34. [PMID: 36173625 DOI: 10.18632/aging.204313] [Reference Citation Analysis]
14 Chen F, Yang L, Peng X, Mao M, Liu X, Song J, Hu J. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma. Mol Immunol 2022;151:204-17. [PMID: 36179603 DOI: 10.1016/j.molimm.2022.09.005] [Reference Citation Analysis]
15 Wang J, Han Y, Li Y, Zhang F, Cai M, Zhang X, Chen J, Ji C, Ma J, Xu F. Targeting Tumor Physical Microenvironment for Improved Radiotherapy. Small Methods. [DOI: 10.1002/smtd.202200570] [Reference Citation Analysis]
16 Lin Z, Wu Y, Xiao X, Zhang X, Wan J, Zheng T, Chen H, Liu T, Tang X. Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy. Front Genet 2022;13:938510. [DOI: 10.3389/fgene.2022.938510] [Reference Citation Analysis]
17 Stuckel AJ, Khare T, Bissonnette M, Khare S. Aberrant regulation of CXCR4 in cancer via deviant microRNA-targeted interactions. Epigenetics 2022;:1-14. [PMID: 36047714 DOI: 10.1080/15592294.2022.2118947] [Reference Citation Analysis]
18 Hadebe B, Sathekge MM, Aldous C, Vorster M. Current Status of 68Ga-Pentixafor in Solid Tumours. Diagnostics 2022;12:2135. [DOI: 10.3390/diagnostics12092135] [Reference Citation Analysis]
19 Gautam SK, Basu S, Aithal A, Dwivedi NV, Gulati M, Jain M. Regulation of pancreatic cancer therapy resistance by chemokines. Semin Cancer Biol 2022:S1044-579X(22)00196-1. [PMID: 36064086 DOI: 10.1016/j.semcancer.2022.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Xie Y, Wu H, Hu W, Zhang H, Li A, Zhang Z, Ren S, Zhang X. Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population. Pathol Oncol Res 2022;28:1610455. [DOI: 10.3389/pore.2022.1610455] [Reference Citation Analysis]
21 Lu T, Zhang J, Lu S, Yang F, Gan L, Wu X, Liu S, Xu C, Han D, Yang B, Wen W, Qin W, Yang L. Endosialin positive tumor derived pericytes promote tumor progression through impeding the infiltration of CD8 + T cells in clear cell renal cell carcinoma.. [DOI: 10.21203/rs.3.rs-1920249/v1] [Reference Citation Analysis]
22 Tan C, Tan S, Zhang H, Zhang M, Fan H, Nan Z, Liu X, Wang W, Zhang L, Deng S, Zuo D, Tang Q. Enhanced migration and immunoregulatory capacity of BMSCs mediated by overexpression of CXCR4 and IL-35. Mol Immunol 2022;150:1-8. [PMID: 35908411 DOI: 10.1016/j.molimm.2022.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kapoor R, Saini A, Sharma D. Indispensable role of microbes in anticancer drugs and discovery trends. Appl Microbiol Biotechnol 2022. [PMID: 35819512 DOI: 10.1007/s00253-022-12046-2] [Reference Citation Analysis]
24 van der Heide CD, Dalm SU. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine. Eur J Nucl Med Mol Imaging 2022. [PMID: 35788730 DOI: 10.1007/s00259-022-05870-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Xu J, Li J, Chen Q, Shestakova EA, Misyurin VA, Pokrovsky VS, Tchevkina EM, Chen H, Song H, Zhang J. Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer. Front Pharmacol 2022;13:920779. [DOI: 10.3389/fphar.2022.920779] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zi D, Li Q, Xu CX, Zhou ZW, Song GB, Hu CB, Wen F, Yang HL, Nie L, Zhao X, Tan J, Zhou SF, He ZX. CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma. Aging (Albany NY) 2022;14:4673-98. [PMID: 35681259 DOI: 10.18632/aging.203241] [Reference Citation Analysis]
27 Cao P, Yang M, Chang C, Wu H, Lu Q. Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases: from Basic Research to Clinical Trials. Clin Rev Allergy Immunol 2022. [PMID: 35674978 DOI: 10.1007/s12016-022-08936-y] [Reference Citation Analysis]
28 Chen K, Gao H, Yao Y. Prospects of cell chemotactic factors in bone and cartilage tissue engineering. Expert Opinion on Biological Therapy. [DOI: 10.1080/14712598.2022.2087471] [Reference Citation Analysis]
29 Wang YC, Lu S, Zhou XJ, Yang L, Liu P, Zhang L, Hu Y, Dong XZ. miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis. Open Med (Wars) 2022;17:930-46. [PMID: 35647303 DOI: 10.1515/med-2022-0486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm (2020) 2022;3:e147. [PMID: 35702353 DOI: 10.1002/mco2.147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Huang X, Cao Y, Bao P, Zhu B, Cheng Z. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity. Cancer Med 2022. [PMID: 35634680 DOI: 10.1002/cam4.4895] [Reference Citation Analysis]
32 Malakouti P, Mohammadi M, Boshagh MA, Amini A, Rezaee MA, Rahmani MR. Combined effects of pioglitazone and doxorubicin on migration and invasion of MDA-MB-231 breast cancer cells. J Egypt Natl Canc Inst 2022;34:13. [PMID: 35342925 DOI: 10.1186/s43046-022-00110-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Guo J, Tong CY, Shi JG, Li XJ. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway. Bioengineered 2022;13:7425-38. [PMID: 35264069 DOI: 10.1080/21655979.2022.2048984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yanagihara K, Iino Y, Yokozaki H, Kubo T, Oda T, Kubo T, Komatsu M, Sasaki H, Ichikawa H, Kuwata T, Seyama T, Ochiai A. A Comparative Study of Patient-Derived Tumor Models of Pancreatic Ductal Adenocarcinoma Involving Orthotopic Implantation. Pathobiology 2022;:1-11. [PMID: 35272288 DOI: 10.1159/000521714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, Yu X, Lu X, Fan X. Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Dorman K, Heinemann V, Kobold S, von Bergwelt-Baildon M, Boeck S. Novel systemic treatment approaches for metastatic pancreatic cancer. Expert Opin Investig Drugs 2022. [PMID: 35114868 DOI: 10.1080/13543784.2022.2037552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 34997230 DOI: 10.1038/s41571-021-00588-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 42.0] [Reference Citation Analysis]
38 Kim S, Yeo MK, Kim JS, Kim JY, Kim KH. Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker. J Cancer 2022;13:162-73. [PMID: 34976180 DOI: 10.7150/jca.64082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Malik S, Westcott JM, Brekken RA, Burrows FJ. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target. Cancers (Basel) 2021;14:86. [PMID: 35008248 DOI: 10.3390/cancers14010086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, Song K, Xu RH. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer 2021;20:166. [PMID: 34911533 DOI: 10.1186/s12943-021-01475-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
41 Liu C, Wang M, Xu C, Li B, Chen J, Chen J, Wang Z. Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation. J Immunol Res 2021;2021:8970173. [PMID: 34877360 DOI: 10.1155/2021/8970173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
42 Gu R, Wang L, Zhou H, Wang X, Lenahan C, Qu H, Liu Y, Li S, Wei C, Han L, Hu X, Zuo G. Rh-CXCL-12 Attenuates Neuronal Pyroptosis after Subarachnoid Hemorrhage in Rats via Regulating the CXCR4/NLRP1 Pathway. Oxid Med Cell Longev 2021;2021:6966394. [PMID: 34795842 DOI: 10.1155/2021/6966394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Tao Y, Li YH, Zhang D, Xu L, Chen JJ, Sang YF, Piao HL, Jing XL, Yu M, Fu Q, Zhou ST, Li DJ, Du MR. Decidual CXCR4+ CD56bright NK cells as a novel NK subset in maternal-foetal immune tolerance to alleviate early pregnancy failure. Clin Transl Med 2021;11:e540. [PMID: 34709764 DOI: 10.1002/ctm2.540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
44 Tang H, Liang Y, Xu S, Xia R, Shen J, Zhang Y, Gong X, Min Y, Zhang D, Zhao T, Wang S, Zhang Y, Wang C. Expression of Four Autophagy-Related Genes Accurately Predicts the Prognosis of Gastrointestinal Cancer in Asian Patients. Dis Markers 2021;2021:7253633. [PMID: 34484469 DOI: 10.1155/2021/7253633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang S, Gao S, Li Y, Qian X, Luan J, Lv X. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Front Cell Dev Biol 2021;9:716842. [PMID: 34386499 DOI: 10.3389/fcell.2021.716842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 164] [Cited by in F6Publishing: 193] [Article Influence: 164.0] [Reference Citation Analysis]
47 Khare T, Bissonnette M, Khare S. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. Int J Mol Sci 2021;22:7371. [PMID: 34298991 DOI: 10.3390/ijms22147371] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
48 Bagmut I, Movchan O, Gramatiuk S. GIPERCRYOGLOBULINEMIA SUCH PATOPHYSIOLOGICAL LINK IN THE POSTOPERATIVE COMLICATIONS FOR STOMACH CANCER PATIENTS. Med Sci of Ukr 2021;17:77-81. [DOI: 10.32345/2664-4738.2.2021.11] [Reference Citation Analysis]
49 Nam AR, Yoon J, Jin MH, Bang JH, Oh KS, Seo HR, Kim JM, Kim TY, Oh DY. ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer. Cancer Lett 2021;516:38-47. [PMID: 34082024 DOI: 10.1016/j.canlet.2021.05.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
50 Chen H, Li G, Liu Y, Ji S, Li Y, Xiang J, Zhou L, Gao H, Zhang W, Sun X, Fu X, Li B. Pleiotropic Roles of CXCR4 in Wound Repair and Regeneration. Front Immunol 2021;12:668758. [PMID: 34122427 DOI: 10.3389/fimmu.2021.668758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
51 Li J, Zheng L, Li C, Xiao Y, Liu J, Wu S, Zhang B. Mannose modified zwitterionic polyester-conjugated second near-infrared organic fluorophore for targeted photothermal therapy. Biomater Sci 2021;9:4648-61. [PMID: 34008632 DOI: 10.1039/d1bm00396h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
52 Bu F, Zhu X, Liu S, Lin K, Zhu J, Huang J. Comprehensive analysis of Syk gene methylation in colorectal cancer. Immun Inflamm Dis 2021;9:923-31. [PMID: 33979042 DOI: 10.1002/iid3.449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
53 Tal A, Tal R, Kliman HJ, Taylor HS. Loss of Cxcr4 in Endometriosis Reduces Proliferation and Lesion Number while Increasing Intraepithelial Lymphocyte Infiltration. Am J Pathol 2021;191:1292-302. [PMID: 33964217 DOI: 10.1016/j.ajpath.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Jiang YQ, Wang ZX, Zhong M, Shen LJ, Han X, Zou X, Liu XY, Deng YN, Yang Y, Chen GH, Deng W, Huang JH. Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data. Oncoimmunology 2021;10:1908010. [PMID: 33868792 DOI: 10.1080/2162402X.2021.1908010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
55 Jang JW, Thuy PX, Lee JW, Moon EY. CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1α under hypoxic conditions. Cell Death Dis 2021;12:330. [PMID: 33771976 DOI: 10.1038/s41419-021-03615-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
56 Walter SG, Scheidt S, Nißler R, Gaisendrees C, Zarghooni K, Schildberg FA. In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets. Cancers (Basel) 2021;13:1466. [PMID: 33806802 DOI: 10.3390/cancers13061466] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
57 Wu X, Zhang H, Sui Z, Wang Y, Yu Z. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biol Med 2021:j. [PMID: 33710803 DOI: 10.20892/j.issn.2095-3941.2020.0140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Garcia-Sampedro A, Gaggia G, Ney A, Mahamed I, Acedo P. The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies. J Clin Med 2021;10:566. [PMID: 33546207 DOI: 10.3390/jcm10040566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
59 López-Gil JC, Martin-Hijano L, Hermann PC, Sainz B Jr. The CXCL12 Crossroads in Cancer Stem Cells and Their Niche. Cancers (Basel) 2021;13:469. [PMID: 33530455 DOI: 10.3390/cancers13030469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
60 Louault K, Li RR, DeClerck YA. Cancer-Associated Fibroblasts: Understanding Their Heterogeneity. Cancers (Basel) 2020;12:E3108. [PMID: 33114328 DOI: 10.3390/cancers12113108] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 21.5] [Reference Citation Analysis]
61 Shi J, Wang K, Xiong Z, Yuan C, Wang C, Cao Q, Yu H, Meng X, Xie K, Cheng Z, Yang H, Chen K, Zhang X. Impact of inflammation and immunotherapy in renal cell carcinoma. Oncol Lett 2020;20:272. [PMID: 33014151 DOI: 10.3892/ol.2020.12135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, Zhang Y, Zheng P. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci 2020;111:4041-50. [PMID: 32860283 DOI: 10.1111/cas.14634] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 12.5] [Reference Citation Analysis]
63 Manfredi F, Cianciotti BC, Potenza A, Tassi E, Noviello M, Biondi A, Ciceri F, Bonini C, Ruggiero E. TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals. Front Immunol 2020;11:1689. [PMID: 33013822 DOI: 10.3389/fimmu.2020.01689] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 18.5] [Reference Citation Analysis]
64 Hermanowicz JM, Kwiatkowska I, Pawlak D. Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 2020;11:3078-101. [PMID: 32850012 DOI: 10.18632/oncotarget.27689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Malfitano AM, Pisanti S, Napolitano F, Di Somma S, Martinelli R, Portella G. Tumor-Associated Macrophage Status in Cancer Treatment. Cancers (Basel) 2020;12:E1987. [PMID: 32708142 DOI: 10.3390/cancers12071987] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 29.5] [Reference Citation Analysis]
66 Song Y, Jin D, Chen J, Luo Z, Chen G, Yang Y, Liu X. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Aging (Albany NY) 2020;12:12051-73. [PMID: 32579540 DOI: 10.18632/aging.103369] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
67 Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, Gockel I, Gromnitza S, Hillmer AM, Chon SH, Schlösser HA, Bruns CJ, Zhao Y. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020;9:E1481. [PMID: 32560537 DOI: 10.3390/cells9061481] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
68 Zhang Q, Miao Y, Fu Q, Hu H, Chen H, Zeng A, Jin Y, Jiang Y, Qian L, Wu L, Xu L, Wang G, Qiu L, Huang X, Xia Y. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis. Biochemical and Biophysical Research Communications 2020;526:713-20. [DOI: 10.1016/j.bbrc.2020.03.156] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
69 Heidary Z, Ghaisari J, Moein S, Haghjooy Javanmard S. The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach. PLoS One 2020;15:e0232965. [PMID: 32384110 DOI: 10.1371/journal.pone.0232965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
70 Li X, Wang X, Li Z, Liu Y, Sang L, Zhang Z, Zhang Y. Expression and regulation effects of chemokine receptor 7 in colon cancer cells. Oncol Lett 2020;20:226-34. [PMID: 32565949 DOI: 10.3892/ol.2020.11561] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Zhang Y, Ou DH, Zhuang DW, Zheng ZF, Lin ME. In silico analysis of the immune microenvironment in bladder cancer. BMC Cancer 2020;20:265. [PMID: 32228629 DOI: 10.1186/s12885-020-06740-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
72 范 延. SDF-1/CXCR4/CXCR7 Are Jointly Involved in the Regeneration and Repair of Nerve Function after Stroke. ACM 2020;10:1360-1366. [DOI: 10.12677/acm.2020.107205] [Reference Citation Analysis]